These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24100721)

  • 1. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease.
    D'Alessio S; Tacconi C; Fiocchi C; Danese S
    Curr Opin Gastroenterol; 2013 Nov; 29(6):608-13. PubMed ID: 24100721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'.
    Danese S
    Gut; 2011 Jul; 60(7):998-1008. PubMed ID: 21212253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
    Hatoum OA; Heidemann J; Binion DG
    Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of lymphatics in inflammatory bowel disease.
    Alexander JS; Chaitanya GV; Grisham MB; Boktor M
    Ann N Y Acad Sci; 2010 Oct; 1207 Suppl 1():E75-85. PubMed ID: 20961310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms.
    Becker F; Yi P; Al-Kofahi M; Ganta VC; Morris J; Alexander JS
    Lymphology; 2014 Mar; 47(1):3-27. PubMed ID: 25109166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
    Danese S; Semeraro S; Marini M; Roberto I; Armuzzi A; Papa A; Gasbarrini A
    Dig Liver Dis; 2005 Nov; 37(11):811-8. PubMed ID: 16168725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.
    Danese S
    Pathobiology; 2008; 75(1):22-4. PubMed ID: 18334836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.
    Zhang L; Ocansey DKW; Liu L; Olovo CV; Zhang X; Qian H; Xu W; Mao F
    Biomed Pharmacother; 2021 Aug; 140():111752. PubMed ID: 34044275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
    Chidlow JH; Shukla D; Grisham MB; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells.
    Imai S; Yoshida Y; Okamura T; Nagano K; Abe Y; Yoshikawa T; Kamada H; Nakagawa S; Tsunoda S; Tsutsumi Y
    Pharmazie; 2009 Mar; 64(3):214-6. PubMed ID: 19348346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease.
    Goebel S; Huang M; Davis WC; Jennings M; Siahaan TJ; Alexander JS; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G648-54. PubMed ID: 16293653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
    Punekar S; Zak S; Kalter VG; Dobransky L; Punekar I; Lawler JW; Gutierrez LS
    Pathobiology; 2008; 75(1):9-21. PubMed ID: 18334835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
    Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
    Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease.
    Binion DG; Rafiee P
    Gastroenterology; 2009 Feb; 136(2):400-3. PubMed ID: 19111728
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.
    Ocansey DKW; Pei B; Xu X; Zhang L; Olovo CV; Mao F
    J Transl Med; 2021 Jun; 19(1):254. PubMed ID: 34112196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the endothelium in inflammatory bowel diseases.
    Cromer WE; Mathis JM; Granger DN; Chaitanya GV; Alexander JS
    World J Gastroenterol; 2011 Feb; 17(5):578-93. PubMed ID: 21350707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.